Publikationen, an denen er mitarbeitet REBECA LORCA GUTIERREZ (52)

2024

  1. Concealed Inherited Cardiomyopathies Detected in Cardio-Oncology Screening

    Journal of Clinical Medicine, Vol. 13, Núm. 1

  2. Natural History of Dilated Cardiomyopathy Due to c.77T>C (p.Val26Ala) in Emerin Protein

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  3. Retrospective variant reclassification and resequencing in hypertrophic cardiomyopathy: a reference unit centre experience

    European Journal of Preventive Cardiology, Vol. 31, Núm. 6, pp. e38-e41

  4. Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing

    International Journal of Cardiology, Vol. 408

  5. “Inherited cardiovascular disease mindset” can identify concealed inherited conditions at cardio-oncology evaluation: An opportunistic screening.

    International Journal of Cardiology, Vol. 401

2023

  1. Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  2. Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  3. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  4. Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  5. STEMI in women. Life expectancy recovery after primary percutaneous coronary intervention

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1003-1012

2022

  1. Association of the Genetic Variation in the Long Non‐Coding RNA FENDRR with the Risk of Developing Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 6

  2. Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 9

  3. KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort

    Life, Vol. 12, Núm. 4

  4. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  5. Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR: A Propensity Score Analysis

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 2, pp. 150-161

2021

  1. Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders

    Clinical Genetics, Vol. 99, Núm. 3, pp. 457-461

  2. Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO-SOR study

    Liver International, Vol. 41, Núm. 9, pp. 2200-2211

  3. Frailty assessment in a cohort of elderly patients with severe symptomatic aortic stenosis: Insights from the frailty evaluation in severe aortic stenosis (fresas) registry

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  4. Premature stemi in men and women: Current clinical features and improvements in management and prognosis

    Journal of Clinical Medicine, Vol. 10, Núm. 6

  5. STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 829-837